These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis. Wojtkiewicz A; Wysocki M; Fortuna J; Chrupek M; Matczuk M; Koltan A Acta Derm Venereol; 2008; 88(4):420-1. PubMed ID: 18709327 [No Abstract] [Full Text] [Related]
5. Infliximab/Plasmapheresis in vanishing bile duct syndrome secondary to toxic epidermal necrolysis. White JC; Appleman S Pediatrics; 2014 Oct; 134(4):e1194-8. PubMed ID: 25246624 [TBL] [Abstract][Full Text] [Related]
6. Effect of N-acetylcysteine combined with infliximab on toxic epidermal necrolysis. A proof-of-concept study. Paquet P; Jennes S; Rousseau AF; Libon F; Delvenne P; Piérard GE Burns; 2014 Dec; 40(8):1707-12. PubMed ID: 24726294 [TBL] [Abstract][Full Text] [Related]
14. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors: An update on infliximab. Brunasso AM; Massone C Acta Derm Venereol; 2011 Jan; 91(1):70-1. PubMed ID: 21103830 [No Abstract] [Full Text] [Related]
15. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study. Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923 [TBL] [Abstract][Full Text] [Related]
16. Response of severe psoriasis to infliximab. Mang R; Stege H; Ruzicka T; Krutmann J Dermatology; 2002; 204(2):156-7. PubMed ID: 11937748 [No Abstract] [Full Text] [Related]
17. Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases. Cocco A; Angelucci E; Viscido A; Caprilli R Inflamm Bowel Dis; 2007 Oct; 13(10):1317-9. PubMed ID: 17508417 [No Abstract] [Full Text] [Related]
18. Infliximab therapy failure in two patients with pemphigus vulgaris. García-Rabasco A; Alsina-Gibert M; Pau-Charles I; Iranzo P J Am Acad Dermatol; 2012 Nov; 67(5):e196-7. PubMed ID: 23062908 [No Abstract] [Full Text] [Related]
19. Infliximab in the management of severe pemphigus vulgaris. Pardo J; Mercader P; Mahiques L; Sanchez-Carazo JL; Oliver V; Fortea JM Br J Dermatol; 2005 Jul; 153(1):222-3. PubMed ID: 16029365 [No Abstract] [Full Text] [Related]
20. Use of infliximab in toxic epidermal necrolysis: a still opened challenge. Ganzetti G; Campanati A; Simonetti O; Giuliodori K; Giangiacomi M; Lemme G; Offidani A G Ital Dermatol Venereol; 2015 Aug; 150(4):467-71. PubMed ID: 25394212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]